Stock summary: Enveric Biosciences declined by 55.78% over the past five days amid $5 million public offerings made by the company

Enveric Biosciences Inc closed at 2.09 USD, reflecting a significant decline of 2.64 points (-55.78%) over the past five days.

Advertisement

Enveric Biosciences Inc closed at 2.09 USD, reflecting a significant decline of 2.64 points (-55.78%) over the past five days. As of January 31 at 7:56 PM GMT-5, the stock experienced a sharp drop, indicating a notable loss of investor confidence driven by the health technology company’s decision to price a $5 million public offering. 

 In after-hours trading, the stock slightly rebounded to 2.10 USD, gaining 0.0100 points (0.48%), suggesting some mild recovery. During the session, Enveric Biosciences reached a high of 2.40 USD, showing a brief period of positive movement, but the stock faced downward pressure as it closed comparatively lower. The low of 2.00 USD highlights a drop in value during the trading session, with the stock bottoming out at its lowest point before slightly recovering. The opening price of the stock was placed at  2.40 USD. With a market capitalization of 14.47L, Enveric Biosciences remains a smaller player in the biotech space. 

Disclaimer: This article is for informational purposes only and does not constitute any financial advice.

Advertisement